April 2, 2018
Prof. Aikou Okamoto, Jikei University School of Medicine Lynparza (olaparib) is desirable for use in early-stage maintenance therapy for ovarian cancer, said Aikou Okamoto, professor of the Department of Obstetrics and Gynecology at the Jikei University School of Medicine, at...read more